Patents by Inventor Samuel Reichgott

Samuel Reichgott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11426105
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: August 30, 2022
    Assignee: Masimo Corporation
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Publication number: 20190357823
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Application
    Filed: June 18, 2019
    Publication date: November 28, 2019
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Patent number: 10368787
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: August 6, 2019
    Assignee: MASIMO CORPORATION
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Publication number: 20160058347
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 3, 2016
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Patent number: 9060721
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: June 23, 2015
    Assignee: GLT ACQUISITION CORP.
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Publication number: 20140051952
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: GLT ACQUISITION CORP.
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Patent number: 8571617
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Grant
    Filed: March 4, 2009
    Date of Patent: October 29, 2013
    Assignee: GLT Acquisition Corp.
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman
  • Patent number: 7640571
    Abstract: A method and device prevent a set-top terminal from accepting a download of new programming or data over a cable network when the download would be redundant of information already possessed by the set-top terminal or would cause an inconvenience to subscribers. When the set-top terminal is signaled that a new download is being offered, the set-top terminal checks to see if the download in fact contains a newer version of data or programming than is currently resident in the set-top terminal. The set-top terminal also checks whether criteria for accepting a download are met. The criteria are conditions that tend to indicate that an interruption of service to accept a download would not inconvenience the subscriber at that time. When the criteria are met, the download is accepted. Otherwise, the download is not accepted or is not accepted until the criteria are satisfied.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: December 29, 2009
    Assignee: General Instrument Corporation
    Inventors: Samuel Reichgott, Abhijit Chatterjee, Charles Schell
  • Publication number: 20090275812
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Application
    Filed: March 4, 2009
    Publication date: November 5, 2009
    Applicant: GlucoLight Corporation
    Inventors: Samuel Reichgott, Walter J. Shakespeare, George Kechter, Phillip William Wallace, Matthew J. Schurman